GLOBALTRADE-CORP.
14.5.2020 17:26:12 CEST | Business Wire | Press release
GlobalTrade Corporation (GTC) has announced today that PORR AG (PORR), one of the largest construction companies in Austria, has selected its @GlobalTrade™ Multi-bank Trade Finance Platform for managing its bank guarantees and surety bonds. PORR employees will use the Platform to access transactions on-line from any place in the world and electronically connect PORR Treasury with its financial institutions.
PORR will manage outgoing transactions with @GlobalTrade™ Guarantee Issuance System http://www.globaltradecorp.com/solutions/standby-lc-guarantee-issuance/ and incoming transactions with @GlobalTrade™ Guarantee Receipt System http://www.globaltradecorp.com/solutions/standby-lc-guarantee-receipt/ .
‘The decision to adopt an electronic platform for the management of guarantees has been made before the Covid-19 pandemic,’ said Alfred Gabler, Head of Group Treasury PORR AG. ‘With the new reality and the need to access real time information from outside the office as well as to digitize as many financial processes as possible, those platforms have become a must have for every company,’ added Gabler.
‘With the need to work from home, our clients have told us how much they appreciate the ability to access their trade finance transactions remotely. Being able to create, approve and send new transactions to their financial institutions electronically is a great advantage’, said Stephen Andersen, GTC’s Vice President Professional Services & Client Support. ‘We are honored that PORR has trusted GTC to start the project under the Covid-19 restrictions. GTC has been implementing projects remotely for many years, which allows us to serve our clients efficiently even during these challenging times,’ added Andersen.
About PORR
Driving innovation for excellence – that’s what PORR stands for since already over 150 years. With around 20,000 employees and a production output of around EUR 5.6 billion (as at 31.12.2019), it is one of the largest construction companies in Austria and among Europe’s leading providers in the sector. As a full-service provider, PORR offers every service in building construction, civil engineering and infrastructure construction, covering the entire value chain. PORR focuses on its home markets Austria, Germany, Switzerland, Poland, Czech Republic, Slovakia and Romania. On selected international project markets such as in Norway, the UAE and Qatar, PORR focuses on export products in tunnel construction, railway construction and civil engineering. The PORR share is listed in the prime market of Vienna Stock Exchange. Find more information at porr-group.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200514005634/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Merck Collaborates with Versant Ventures to Launch Saturnus Bio to Advance Treatments for Rare Genetic Cardiomyopathies23.6.2026 15:30:00 CEST | Press release
Saturnus Bio is a next-generation precision cardiology company that utilizes targeted gene modulation to address rare mono-genetic cardiomyopathies with significant unmet needThe collaboration will augment Merck’s efforts to pursue precision medicine-defined indicationsNot intended for Canada-, UK- or US-based media Merck, a leading global science and technology company, today announced a strategic research-stage collaboration with Saturnus Bio, a Versant Ventures-founded biotech, aimed at establishing a foundational portfolio in the promising field of rare genetic cardiomyopathies. This partnership aligns with the company’s commitment to address significant unmet medical needs in rare populations through targeted treatments. “Through our partnership with Saturnus Bio, we aim to fast track the development of innovative therapies for genetic cardiomyopathies through precision cardiology, targeting the rare population impacted by these conditions,” said David Weinreich, MD, Head of Resea
Beyond the ‘Dumb Pipe’: How Agentic AI and Sovereign Networks Are Redefining Connectivity23.6.2026 14:46:00 CEST | Press release
The global connectivity market is shifting. With traditional European telecom growth slowing to 2-3% by 2029, businesses must adapt through Agentic AI, critical communications, and digital sovereignty. To remain competitive, operators should move beyond infrastructure toward an API-driven economy. These trends took center stage at Comarch User Group 2026. The conference hosted over 700 partners from 53 countries, including 201 connectivity experts, highlighting how companies can thrive in regulated environments. As telecom growth slows, demand for broader connectivity solutions across satellite, logistics, and critical communications is surging. Operators must abandon the old 4G “dumb pipe” model, where they act merely as network providers charging only for raw data transmission, for an API-driven economy with programmable network quality, securely integrating 5G with new satellite and IoT ecosystems. - Marcin Kaleta, CEO at Comarch Communications Putting Agentic AI in the Driver's Sea
Mary Kay Extends Winning Streak With Fourth Year as #1 in Global Direct Selling Beauty23.6.2026 14:03:00 CEST | Press release
Euromonitor International Recognizes Mary Kay’s Sustained Leadership In Skin Care And Color Cosmetics Mary Kay Inc., the iconic beauty and entrepreneurship company, has once again been named the #1 Direct Selling Brand of Skin Care and Color Cosmetics in the World1 by Euromonitor International, sustaining its legacy of excellence for the fourth consecutive year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260623487381/en/ Mary Kay Inc., the iconic beauty and entrepreneurship company, for the fourth year in a row has been named the #1 Direct Selling Brand of Skin Care and Color Cosmetics in the World by Euromonitor International. (Image Credit: Mary Kay Inc.) “Earning the #1 global ranking from Euromonitor for the fourth consecutive year comes as a powerful endorsement of the impact of our Independent Beauty Consultants around the world who drive our success every day,” said Ryan Rogers, Chief Executive Officer of Mary Kay
Kobie 2026 Heart of Loyalty Report Reveals Growing Gap Between Consumer Expectations and Brand Loyalty Strategies23.6.2026 14:00:00 CEST | Press release
Global study finds consumers are more ready for AI, more willing to share data, and more motivated by recognition and shared values than many brands realize Kobie, a global leader in loyalty technology and services, today released its 2026 Heart of Loyalty Report, which surveyed both consumers and practitioners, revealing significant gaps between consumer expectations and brand loyalty strategies across AI adoption, data sharing, recognition, advocacy, and community engagement. Kobie's 2026 Heart of Loyalty Report found that: 57% of consumers are willing to engage with AI-powered brand experiences, yet 56% of loyalty practitioners believe customers are not ready for AI. 77% of consumers want recognition from brands, but only 55% feel seen as individuals. 72% of consumers say they would refer a brand without an incentive, yet many referral strategies remain heavily dependent on rewards. Rewards are the strongest driver of willingness to share personal data, yet only 65% of practitioners
Veristat Strengthens Biostatistics, Drug Development Advisory, and People Leadership to Support Growth in Complex Clinical Development23.6.2026 13:05:00 CEST | Press release
Dr. Zhaohui Su and Dr. Gil Fine deepen Veristat’s biostatistics expertise, Scott Tarrant leads Strategic Drug Development Advisory, and Clint Wolfe joins as Chief Human Resources Officer VeristatTM, a global clinical research organization (CRO) and consultancy specializing in complex studies, today announced four strategic leadership hires that advance its mission to accelerate novel therapy approvals in complex disease areas, including cell and gene therapy, oncology, and rare disease. Building on its 30-year foundation in biostatistics and its recent acquisition of the medical writing and regulatory submission business of Certara, Veristat is deepening its scientific expertise and expanding its operational leadership to meet growing client demand. Dr. Zhaohui Su and Dr. Gil Fine join Veristat’s Strategic Drug Development Advisory team in biostatistical leadership roles, collaborating with Scott Tarrant, who has been named Executive Vice President of the team. In addition, Clint Wolfe
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom